Academic literature on the topic 'Lyophilized powder for solution for injection'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lyophilized powder for solution for injection.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lyophilized powder for solution for injection"

1

Blazheyevskіy, Mykola Ye, Nataliia Yu Bondarenko, and Olena O. Mozgova. "The quantitative determination of glutathione by the effect of the chemiluminescence inhibition in the catalytic oxidation reaction of luminol with hydrogen peroxide in the presence of hemoglobin." Journal of Organic and Pharmaceutical Chemistry 20, no. 1(77) (2022): 51–56. http://dx.doi.org/10.24959/ophcj.22.255967.

Full text
Abstract:
Aim. To develop a method for the quantitative determination of reduced glutathione in a lyophilized powder for the preparation of “Hepaval®” solution for intravenous and intramuscular administration by the effect of inhibiting chemiluminescence in the luminol (H2L)–Н2О2–hemoglobin (Hb) system.Materials and methods. The study object was the reduced glutathione substance and lyophilized powder for the preparation of “Hepaval®” solution for injection, ampoules of 4 mL No. 10 manufactured by “Valartin pharma” (Italy). The glutathione content in powder was determined using the chemiluminescence method by the effect of inhibiting the luminol oxidation reaction with hydrogen peroxide in the presence of Hb as a catalyst. The analysis was performed by the standard addition method.Results and discussion. As a result of the studies, it has been found that under optimal conditions glutathione shows a noticeable inhibitory effect on chemiluminescence in the H2L–H2O2–Hb system. This phenomenon was used to develop a new procedure for the quantitative determination of glutathione in the substance and lyophilized powder for the preparation of “Hepaval®” aqueous solution for injection. The linear dependence of the integral chemiluminescence intencity (S) on the molar concentration of glutathione was maintained in the concentration range of (2 – 20) × 10–7 mol L-1. The graph equation was S = (–1.6 ± 0.2) × 107 × c + (198.9 ± 2.0), (r = 0.999). The relative standard deviation (RSD) was ±1.82 % (n = 7, P = 0.95). Conclusions. The method has been developed, and the possibility of the quantitative determination of glutathione in powder for the preparation of “Hepaval®” solution for injection by the method of the chemiluminescence inhibition of the H2L–Н2О2–Нb system has been shown. The content of glutathione in powder calculated with reference to dried substance was 91.49 % (against 90.8 % by the certificate). The accuracy was +0.76 %.
APA, Harvard, Vancouver, ISO, and other styles
2

Bukkawar, Amit R., Amit K. Jain, and Vivekanand K. Chatap. "Development and Evaluation of Vasoactive Intestinal Peptide Freeze-Dried Injection." INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY 13, no. 02 (2022): 597–604. http://dx.doi.org/10.25258/ijddt.13.2.21.

Full text
Abstract:
Introduction: Vasoactive intestinal peptide (VIP), a ubiquitous, naturally synthesized human peptide is extensively documented to have diverse physiological effects like anti-inflammatory, immune-modulatory, anti-hypertensive, stimulation of contractility in the heart, vasodilation, and promoting neuroendocrine-immune communication. The synthetic form of VIP is called aviptadil (AVP). The main objective of this research was to develop a novel stable lyophilized dosage of VIP (Aviptadil) using sucrose as a bulking agent. AVP is a peptide with known concern for aqueous stability, which seems to be challenging for storing finished drug products and supply chain management. The VIP injection was developed using the lyophilization technique in the presence of bulking agent and some other pH-adjusting agent. The bulking agent and solvent system selection depends upon the solubility, stability of the drug substance, and feasibility during manufacturing. During product formulation development, the bulk solution was evaluated for processing time and temperature impact. The lyophilization cycle was developed using the most advanced freeze-drying technology. Result and discussion: With the usage of bulking agent (sucrose) as may act as a cryoprotectant for peptide, the formulated bulk solution was freeze-dried, and primary drying was done at-25°C (below than critical product temperature) followed by secondary drying at 25°C. The critical quality attributes of lyophilized drug products like the description of lyophilized cake/powder, moisture content, reconstitution time, active drug content and color of the solution were evaluated. The developed formulation bulk solution was stable and compatible with contact materials like SS vessels when hold up to 24 hours at 2 to 8°C. The optimized freeze-dried product meets the predefined acceptance criteria as part of the quality target product profile. Conclusions: It can be concluded from the research work carried out that a stable lyophilized parenteral formulation containing VIP (AVP) was developed using sucrose as a bulking agent. These findings show that the freeze-dried formulation is an appropriate technological remedy for stabilizing VIP in lyophilized injectable dosage form.
APA, Harvard, Vancouver, ISO, and other styles
3

Saliy, E. A., A. Yu Honcharuk, O. V. Getalo, and H. V. Tarasenko. "DEVELOPMENT AND EVALUATION OF LYOPHILIZED POWDER TO PREPARE SOLUTION FOR INJECTIONS BASED ON DOXYCYCLINE." Vestnik Farmacii 93, no. 3 (2021): 53–63. http://dx.doi.org/10.52540/2074-9457.2021.3.53.

Full text
Abstract:
The range of doxycycline drugs on the pharmaceutical market of the Ukraine is very limited and is represented by solid forms (capsules and tablets) while a rapid effect and maximum bioavailability of the drug can be provided by parenteral administration. The object of the study is the drug doxycycline hyclate in the form of lyophilisate to prepare solution for injections. During the development of the drug it was taken into account that aqueous doxycycline solution is pH dependent and tends to shift the solution pH during long-term storage. Therefore, excipients such as stabilizer and antioxidant providing buffering properties and stability of the solution were introduced into the composition. According to the research results an optimal composition of lyophilized powder was selected, the production technology with the stage of solution treatment with activated carbon was developed which allowed to obtain lyophilized powder with a well-formed porous mass without splits, cracks and fissures, resistant to shaking, and the prepared solution for parenteral administration is stable by the «Degree of coloration» quality indicator during accelerated storage regimen. It was found that doxycycline hyclate in the form of a lyophilisate shows a wide range of antibacterial activity. Comparative studies in vitro for two drugs, in the form of lyophilisate with doxycycline hyclate for injections and hard gelatin capsules with 100 mg of doxycycline hyclate, confirm equivalence of their bacteriostatic action against bacteria causing infectious diseases in humans.
APA, Harvard, Vancouver, ISO, and other styles
4

A. Hussein, Ahmed, and Hasanain Sh. Mahmood. "Preparation and Evaluation of Cefixime Nanocrystals." Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512) 23, no. 2 (2017): 1–12. http://dx.doi.org/10.31351/vol23iss2pp1-12.

Full text
Abstract:
Drug nanocrystals are nanoscopic crystals of the parent compound with dimensions less than 1 µm. A decrease in particle size will lead to an increase in effective surface area in the diffusion layer, which, in turn, increases the drug dissolution rate. Drug nanocrystals are one of the most important strategies to enhance the oral bioavailability of hydrophobic drugs.
 Cefixime is the first member of what is generally termed the third generation orally active cephalosporins. These third generation cephalosporins are distinct from the older β-lactam antibiotics in their intensive antibacterial activity against a wide range of gram-negative bacteria.
 The aim of this study is to prepare nanocrystals of cefixime as a capsules dosage form in order to increase its oral dissolution rate and bioavailability.
 The cefixime nanocrystals were prepared by solvent/antisolvent precipitation method. Certain amount of drug was dissolved in water miscible solvent (methanol used in this study), then this solution was injected (at certain speed) into water containing stabilizer. Upon injection, precipitation of cefixime nanocrystal will occur immediately; this precipitate is sonicated at 37 ˚C for 30 min. then lyophilized. Powder of nanocrystal was obtained and filled into capsules. The physicochemical interaction between drug and addatives was studied using FTIR, DSC,
 Results show that the best formula of cefixime nanocrystals prepared by dissolving 20mg/ml of cefixime in methanol, then 5ml was injected at 60ml/hr rate to a 50ml PVP solution as stabilizer in concentration 0.05%, then lyophilized to obtain the cefixime nanocrystal powder. The resulted mean particle size was 9-11 nm and the dissolution rate was significantly higher than that of the raw cefixime powder (p>0.05).
 Keywords: Cefixime trihydrate, Nanocrystals, Anti-solvent precipitation, PVP, HPMC, Poloxamer 188.
APA, Harvard, Vancouver, ISO, and other styles
5

Amara, S., I. Ben Slama, I. Mrad, et al. "Effects of zinc oxide nanoparticles and/or zinc chloride on biochemical parameters and mineral levels in rat liver and kidney." Human & Experimental Toxicology 33, no. 11 (2014): 1150–57. http://dx.doi.org/10.1177/0960327113510327.

Full text
Abstract:
The aim of this study was to assess the potential subacute toxicity of zinc oxide (ZnO) nanoparticles (NPs) in Wistar rats in comparison with reference toxicant, zinc chloride (ZnCl2), of a non-nanoparticulate form. We therefore studied the relationships between zinc (Zn) accumulation, liver and kidney trace element levels, and plasmatic biochemical parameters. Rats in all groups were treated by intraperitoneal injection of ZnO NPs and/or ZnCl2 solution (25 mg/kg) every other day for 10 days. The contents of trace element in the liver and kidney were slightly modulated after ZnO NPs and/or ZnCl2 solution exposure. The same treatment increased the aspartate aminotransferase activity and uric acid concentration. However, ZnO NPs or ZnCl2 solution decreased the creatinine levels, whereas the combined intake of ZnO NPs and ZnCl2 decreased the glucose concentration. Interestingly, the analysis of the lyophilized powder of liver using the x-ray diffractometer showed the degradation of ZnO NPs in ZnO-treated group, instead there is a lack of NPs ZnO biosynthesis from the ZnCl2 solution injected in rats. These investigations suggest that combined injection of ZnO NPs and ZnCl2 solution has a possible toxic effect in rats. This effect could be related to Zn2+ ion release and accumulation of this element in organs. Our findings provide crucial information that ZnO appeared to be absorbed in the organs in an ionic form rather than in a particulate form.
APA, Harvard, Vancouver, ISO, and other styles
6

Tykhonov, O. I., L. G. Almakaeva, and O. S. Shpychak. "Development of the technology of a lyophilized powder for preparing the solution for injections based on bee venom." Vìsnik farmacìï, no. 2(98) (August 21, 2019): 20–28. http://dx.doi.org/10.24959/nphj.19.9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sundaramurthi, Prakash, Sean Chadwick, and Chakravarthy Narasimhan. "Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag." Journal of Oncology Pharmacy Practice 26, no. 3 (2019): 641–46. http://dx.doi.org/10.1177/1078155219868516.

Full text
Abstract:
Introduction Pembrolizumab is an anti-PD-1 monoclonal antibody, approved and under development for numerous indications in oncology. It is available as either lyophilized powder for reconstitution or ready-to-use solution. Both are required to be diluted in saline or dextrose solution prior to intravenous infusion. After dilution, the recommendation per summary of product characteristics is 24 h at 2–8℃ and 6 h at room temperature. The purpose of this study was to investigate the physicochemical stability of pembrolizumab diluted solution (1 mg/mL) at both refrigerated and room temperature conditions for an extended period. Methods Under aseptic conditions, pembrolizumab was diluted in 250 mL of saline injection in polyolefin bags to obtain the final protein concentration of 1 mg/mL. Thus, prepared bags were then stored at either 5℃ ± 3℃, refrigerator exposing the product to ambient light or room temperature (20℃ ± 3℃) on the benchtop. Results Using several analytical methods, it was demonstrated that pembrolizumab solution for infusion, diluted in normal saline can be stored in polyolefin infusion bags for at least 1 week at 5℃ or RT with no evidence of chemical or physical instability. No aggregation was observed. Conclusion Thus, the practical use of aseptically prepared diluted pembrolizumab in saline can be safely extended to optimize the workload of centralized preparation units and to minimize costs. However, it is the responsibility of the end-user to maintain overall quality of prepared admixture solution that is administered to patient, by following aseptic compounding process as recommended in the packaging insert.
APA, Harvard, Vancouver, ISO, and other styles
8

Pedroso, Tahisa Marcela, and Hérida Regina Nunes Salgado. "Validation of analytical methodology for quantification of cefazolin sodium pharmaceutical dosage form by high performance liquid chromatography to be applied for quality control in pharmaceutical industry." Brazilian Journal of Pharmaceutical Sciences 50, no. 1 (2014): 213–23. http://dx.doi.org/10.1590/s1984-82502011000100022.

Full text
Abstract:
A reversed-phase high performance liquid chromatography method was validated for the determination of cefazolin sodium in lyophilized powder for solution for injection to be applied for quality control in pharmaceutical industry. The liquid chromatography method was conducted on a Zorbax Eclipse Plus C18 column (250 x 4.6 mm, 5 μm), maintained at room temperature. The mobile phase consisted of purified water: acetonitrile (60: 40 v/v), adjusted to pH 8 with triethylamine. The flow rate was of 0.5 mL min-1 and effluents were monitored at 270 nm. The retention time for cefazolin sodium was 3.6 min. The method proved to be linear (r2=0.9999) over the concentration range of 30-80 µg mL-1. The selectivity of the method was proven through degradation studies. The method demonstrated satisfactory results for precision, accuracy, limits of detection and quantitation. The robustness of this method was evaluated using the Plackett–Burman fractional factorial experimental design with a matrix of 15 experiments and the statistical treatment proposed by Youden and Steiner. Finally, the proposed method could be also an advantageous option for the analysis of cefazolin sodium, contributing to improve the quality control and to assure the therapeutic efficacy.
APA, Harvard, Vancouver, ISO, and other styles
9

Kolpaksidi, A. P., M. V. Dmitrieva, O. L. Orlova, L. V. Ektova, and I. I. Krasniuk. "Application of Solid Dispersion Technology to Obtain a Model of Injectable Dosage Form of Indolocarbazole Derivative." Drug development & registration 11, no. 4 (2022): 73–78. http://dx.doi.org/10.33380/2305-2066-2022-11-4-73-78.

Full text
Abstract:
Introduction. N. N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia synthesized an original derivative of indolocarbazole with the carbohydrate residue xylose, which has a pronounced cytotoxic and anti-angiogenic activity. The substance LCS-1269 is an amorphous powder that is almost insoluble in water, which causes difficulties in the development of an injectable dosage form (IDP). To solve this problem, a technological approach to obtain a solid dispersion (SD) of LCS-1269 has been proposed.Aim. To develop a model of IDP of the indolocarbazole derivative LCS-1269 based on SD.Materials and methods. We used a substance LCS-1269 synthesized in the Chemical Synthesis Laboratory of the N. N. Blokhin National Medical Research Center of Oncology. Emuxol 268, Kolliphor® P 188, Soluplus®, Lutrol® F68, Kollidon® 12 and Kollidon® 17, soybean phosphatidylcholine unsaturated S PC and saturated S PC-3 were investigated as carriers of the active substance. SD LCS-1269 was obtained by solvent removal: the active substance was dissolved in acetone, the carrier − in chloroform, the obtained solutions were mixed, transferred into a bottle and evaporated under vacuum (50 ± 5 mbar) in the desiccator at water bath temperature 65 ± 2 °С. To obtain aqueous solution of LCS-1269 dry mass was dissolved using different auxiliary substances or their mixtures: water for injection, ethanol 95 %, benzyl alcohol, Kollisolv® PEG 400, MONTANOX™ 80. To increase stability, the aqueous solution of LCS-1269 was lyophilized in an Edwards Minifast DO.2 freeze dryer.Results and discussion. Kollidon® 17 was chosen as the carrier material for the SD active substance. It was found that a clear solution of LCS-1269 with the concentration of the active substance 0.5 % was formed by dissolving the SD in ethanol 95 % and then gradually diluting the alcohol mixture with water for injection. In this case, the mass ratio of the components of the developed model IDF LCS : Kollidon® 17 : ethanol : water is 1 : 40 : 32 : 127. As a result of freeze-drying of the water-ethanol solution of LCS-1269 the IDF in the form of lyophilizate easily soluble in a 10 % solution of ethanol was obtained.Conclusion. An IDF model of the hydrophobic derivative of indolocarbazole LCS-1269 based on SD was developed and submitted for biological studies to evaluate its effectiveness.
APA, Harvard, Vancouver, ISO, and other styles
10

Wallace, Stephanie J., Jian Li, Craig R. Rayner, Kingsley Coulthard, and Roger L. Nation. "Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients." Antimicrobial Agents and Chemotherapy 52, no. 9 (2008): 3047–51. http://dx.doi.org/10.1128/aac.00103-08.

Full text
Abstract:
ABSTRACT Colistin methanesulfonate (CMS) has the potential to hydrolyze in aqueous solution to liberate colistin, its microbiologically active and more toxic parent compound. While conversion of CMS to colistin in vivo is important for bactericidal activity, liberation of colistin during storage and/or use of pharmaceutical formulations may potentiate the toxicity of CMS. To date, there has been no information available regarding the stability of CMS in pharmaceutical preparations. Two commercial CMS formulations were investigated for stability with respect to colistin content, which was measured by a specific high-performance liquid chromatography method. Coly-Mycin M Parenteral (colistimethate lyophilized powder) was stable (<0.1% of CMS present as colistin) for at least 20 weeks at 4°C and 25°C at 60% relative humidity. When Coly-Mycin M was reconstituted with 2 ml of water to a CMS concentration of 200 mg/ml for injection, Coly-Mycin M was stable (<0.1% colistin formed) for at least 7 days at both 4°C and 25°C. When further diluted to 4 mg/ml in a glucose (5%) or saline (0.9%) infusion solution as directed, CMS hydrolyzed faster at 25°C (<4% colistin formed after 48 h) than at 4°C (0.3% colistin formed). The second formulation, CMS Solution for Inhalation (77.5 mg/ml), was stable at 4°C and 25°C for at least 12 months, as determined based on colistin content (<0.1%). This study demonstrated the concentration- and temperature-dependent hydrolysis of CMS. The information provided by this study has important implications for the formulation and clinical use of CMS products.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Lyophilized powder for solution for injection"

1

Гончарук, Алла Юріївна. "Обґрунтування складу і технології виробництва ліофілізованого порошку для отримання парентерального лікарського засобу". Магістерська робота, Київський національний університет технологій та дизайну, 2021. https://er.knutd.edu.ua/handle/123456789/19421.

Full text
Abstract:
Дипломну магістерську роботу присвячено розробці та дослідженню композиції парентерального препарату у формі ліофілізованого порошку на основі доксицикліну хіклату. В процесі досліджень було підібрано оптимальний склад допоміжних речовин, що виконують функції антиоксидантів та стабілізаторів розчину, схильного до зміни рН в процесі зберігання. Запропоновано технологію виготовлення з використанням прийому висвітлення сорбентом, обладнання, первинну упаковку, технологічну схему, валідаційний майстер-план та діаграму Ішикави для аналізу ризиків процесу виробництва. Проведені дослідження in vitro ліофілізату та твердих желатинових капсул підтверджують еквівалентність їх бактеріостатичної дії щодо збудників бактеріальних інфекцій. На основі контролю in vivo аномальної токсичності доведено відсутність побічних реакцій протягом 72 годин після введення.<br>Master's thesis is devoted to development and research of composition of parenteral drug in form of lyophilized powder based on doxycycline hyclate. During the studies, the optimal composition of the excipients, acting as antioxidants and stabilisers for a solution prone to pH changes during storage, was selected. A manufacturing technology with the use of technique of solution clarification with sorbent is offered. Еquipment, primary packaging, flow chart, validation master plan and Ishikawa diagram for risk analysis of the manufacturing process was proposed. In vitro studies of lyophilizate and solid gelatin capsules confirm the equivalence of their bacteriostatic action against pathogens of bacterial infections. Based on in vivo control of abnormal toxicity, the absence of adverse reactions within 72 h after administration has been proved.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Lyophilized powder for solution for injection"

1

Hunt, Emily M., Mike Baraky, Benton Allen, Paige Earl, and Trent Kelly. "A Complete Corrosion Solution for Salt, Brackish, and Brine Piping Systems." In CORROSION 2019. NACE International, 2019. https://doi.org/10.5006/c2019-12883.

Full text
Abstract:
Abstract Macro and microbiological growth can have significant impacts on safe and efficient operations in oil &amp; gas applications, especially in water injection and underground storage systems. Operators must provide protection against both chemical and microbial corrosion to protect assets from degradation and failure. High density polyethylene (HDPE) coatings have been shown to provide long-term corrosion protection for salt, brackish, and brine piping. However, HDPE is susceptible to biodegradation. This study explores the development and testing of a novel HDPE coating containing a unique blend of antimicrobial powder additive engineered to protect against common bacteria and fungi in brine water. Experiments were conducted to evaluate the biological and material performance of the coatings. Results from microbiological testing showed that coatings enhanced with the material additive resisted and deactivated over 70% of bacteria present in the brine water and over 90% of the harmful fungi which causes fouling in pipelines. Testing results indicated that the additive has no significant impact on the mechanical properties or corrosion resistance of the HDPE lining. These results are significant because the additive protects against harmful microbes while maintaining properties of the HDPE system. This technology provides transformative change in prevention methods for on-shore brine pipeline applications.
APA, Harvard, Vancouver, ISO, and other styles
2

Qu, Xinlu, Zhang Yiran, Wenyu Wu, and Xiaojun Liu. "Menu optimization of digital twin system based on user experience: A case study of lyophilized injection workshop." In 2025 Intelligent Human Systems Integration. AHFE International, 2025. https://doi.org/10.54941/ahfe1005833.

Full text
Abstract:
Menus are not only a basic user interface element in digital twin systems, but also a key component to improve system usability, user experience, and operational security. Pie menus have been used in SunView, NEWS, and many other systems since Hopkins pioneered them, but they are not widely used in digital twin systems. Previous studies have shown that its usage efficiency is better than that of linear menus, so this paper takes the lyophilized injection workshop digital twin system as an example to verify the user experience differences between pie menus and linear menus within the digital twin system. According to the function of the production line in the lyophilized powder production workshop, the pie menu and linear menu are designed for the interface of the cartoning robotic arm equipment in the intelligent packaging line, and the usability test is used to quantify the user experience data, and through the reliability and validity test and data analysis, it is concluded that the pie menu is higher than the linear menu in terms of ease of learning, use efficiency, usability, and satisfaction, etc., and that the adoption of the pie menu can help to improve user experience.
APA, Harvard, Vancouver, ISO, and other styles
3

Sayımlı, Hakan, Güler Kesici, and Çallıoğlu Cengiz. "Waste potassium based recycle agent preparation and nanofiber production." In 7th International Scientific Conference Contemporary Trends and Innovations in Textile Industry – CT&ITI 2024. Union of Engineers and Technicians of Serbia, Belgrade, 2024. http://dx.doi.org/10.5937/ct_iti24023rs.

Full text
Abstract:
The low potassium content in the foods consumed daily and the absence of potassium in most foods direct people to potassium intake directly through supplementary foods. It is known that large amounts of potassium are present in banana fruit and peel. This study is aimed at utilizing banana peel waste to produce an easy-to-use, thin, lightweight, biocompatible, and innovative nanofibrous material. First of all, waste banana peels were lyophilized with a freeze-dryer device and pulverized with a mixer blender. Next, EDX conducted an elemental analysis of the potassium-containing banana peel powder. Then, PVP-based nanofibers with recycled potassium-containing banana peel powder were produced. PVP solutions containing different concentrations of banana peel powder were prepared under equal conditions, and the solution properties such as conductivity, viscosity, pH, and surface tension were determined. Finally, Scanning Electron Microscopy (SEM) was used to analyze the structural properties of PVP-banana peel powder nanofibers, such as fiber diameter, fiber diameter uniformity coefficient, and elemental analysis with EDX to confirm the presence of potassium in the nanofibrous material. It is thought that these nanofiber surfaces, which can be transformed into a highvalue-added product by evaluating the waste food material, will be especially useful for a treatment for supralingual application of potassium.
APA, Harvard, Vancouver, ISO, and other styles
4

Meza, A., A. Barbosa, X. Yang, E. Tabares, and J. M. Torralba. "Developing Cocrfenimox High Entropy Alloys Using Commodity Powders By Powder Injection Moulding." In Euro Powder Metallurgy 2023 Congress & Exhibition. EPMA, 2023. http://dx.doi.org/10.59499/ep235765012.

Full text
Abstract:
High Entropy Alloys (HEAs) have increasingly attracted the scientific community’s attention due to their unique microstructures and mechanical performance. However, one of the HEAs’ main drawbacks to being developed by powder metallurgy is the need for prealloyed powders with the specific composition of the HEA, which increases the overall cost. Thus, in this work, commercial commodity powders like Ni625, CoCrF75, or 316L were employed to manufacture HEAs by Powder Injection Moulding (PIM). These powders were mixed with a multi-component binder to produce sustainable feedstocks using a combination of low CO2-emitting and water-soluble polymers. The critical solids content was determined, and the rheological properties, debinding conditions, and sintering parameters were adjusted to obtain samples with low porosity. In addition, all PIM stages were thoroughly characterized to control the porosity of the end parts and to ensure a single FCC solid solution with promising mechanical properties in the developed CoCrFeNiMox-type HEAs.
APA, Harvard, Vancouver, ISO, and other styles
5

Mirahmadi, Amin, and Mostafa Rezaee Saraji. "Production Method for Solid Oxide Fuel Cell Substrate Using Powder Injection Molding Process." In ASME 2010 10th Biennial Conference on Engineering Systems Design and Analysis. ASMEDC, 2010. http://dx.doi.org/10.1115/esda2010-24572.

Full text
Abstract:
Solid oxide fuel cells (SOFC) are a promising high-efficient power generating system that can directly convert chemical fuel to electrical power. Cost reduction of materials and processing is one of the key issues for commercialization of SOFCs. Powder injection molding is a good solution for producing low cost and defect free components and is adapted with mass production. In this study, effect of five powder loading and sintering temperature and holding time on porosity and thermal shock characteristics of SOFC substrate is investigated. Finally, the results show powder loading is not key factor in porosity and thermal shock characteristics and it is better to use high powder loadings. High sintering temperature for long time leads to high density sintered parts and are not suitable for SOFC substrate. All parts show high thermal shock characteristics.
APA, Harvard, Vancouver, ISO, and other styles
6

Mager, J., W. R. Cannon, and B. H. Kear. "Plasma Reaction Synthesis of Agglomerated Oxide Powders by Axial Injection Torch." In ITSC2004, edited by Basil R. Marple and Christian Moreau. ASM International, 2004. http://dx.doi.org/10.31399/asm.cp.itsc2004p0679.

Full text
Abstract:
Abstract Several compositions of agglomerated ZrO2(Y2O3), Al2O3 and MgAl2O4 powders were plasma sprayed through an axial injection torch into a water quenching chamber in order to obtain a fully melted and homogenized, metastable particle nanostructure. This metastable extended solid solution morphology allows the powder to be subsequently heat treated and superplastically formed into ceramic parts with potentially excellent optical and mechanical properties. Light microscopy, SEM and XRD analyses were used to evaluate the melt-quenched powder properties, and some comparison was made to previous work performed with traditional radial injection plasma torches. Thick build-ups were also sprayed from the melt-quenched powders to test their ability to superplastically flow. Results showed that during a single processing through the torch the axial injection equipment produced powders with a significantly higher fraction of fully homogenized powders than previously attainable. Homogenization of powders comprised of a larger particle size range was also achieved.
APA, Harvard, Vancouver, ISO, and other styles
7

Shahien, Mohammed, Masato Suzuki, and Kentaro Shinoda Jun Akedo. "Direct Spraying of Fine Ceramic Particles in Thermal Spray." In ITSC2018, edited by F. Azarmi, K. Balani, H. Li, et al. ASM International, 2018. http://dx.doi.org/10.31399/asm.cp.itsc2018p0515.

Full text
Abstract:
Abstract Deposition of ceramic coatings by spraying of fine powder particles is a promising solution to obtain uniform microstructure and improved properties, because it is expected to form small splats with reduced residual stress and pore size. Although direct injection of fine particles has many challenges such as poor rheological properties (e.g., low flow ability and agglomeration), and small momentum to inject and impact, it is still attractive and worth to try. From this point of view, we have improved feeding and injection technique of fine powder particles, which enables us to directly spray fine ceramic particles with a newly developed low power dc plasma torch. Preliminary results obtained with this system will be compared with those by other fine powder spray technology such as suspension plasma spray and hybrid aerosol deposition to show similarity and difference when the injection methods of the fine powder particles are different in this paper.
APA, Harvard, Vancouver, ISO, and other styles
8

Raoelison, Rija Nrina, Sabeur Msolli, Sihao Deng, et al. "A Concept of Aerospike Nozzle for Cold Spray Additive Manufacturing—Towards a Potential Solution for Preventing the Issue of Clogging." In ITSC 2023. ASM International, 2023. http://dx.doi.org/10.31399/asm.cp.itsc2023p0229.

Full text
Abstract:
Abstract The clogging, a frequent gas passage deformation phenomenon because of powder accumulation on inner nozzle wall, is a major issue in long duration Cold Spray (CS) operations and a major challenge for Cold spray technology to be adopted for additive manufacturing. This study aims to design and integrate new nozzle design in Cold Spray operations for addressing the clogging issues in traditional circular convergent-divergent (CD) nozzles. The concept of the Aerospike nozzle is proposed for that purpose and is investigated using numerical simulation methods in this paper. An aerospike nozzle allows gases to accelerate externally bounded by environment on one-side and contoured spike wall on other side. After accelerating along the spike wall, aerospike nozzle can generate a longer supersonic gas stream. The spike region can be truncated near the tip to provide a flat face for powder injection. This proposed strategy will allow powder particles to accelerate through a longer supersonic core region, without interacting with nozzle wall. With appropriate operating parameters, an aerospike nozzle can reduce or eliminate the clogging issue completely. The efficiency and operation of aerospike nozzle is compared with same Mach number C-D nozzle using numerical simulations at stagnation pressure of 30 bar and temperature of 623K, where the aluminium powder particles are injected at 30 g/min in the centerline of both nozzles and are accelerated to similar velocities. The powder particles are accelerated in supersonic core region of aerospike nozzle without interacting with nozzle wall, it is concluded that the aerospike nozzle can be a promising nozzle design to provide clogging free long duration CS operations.
APA, Harvard, Vancouver, ISO, and other styles
9

Gell, Maurice, Fang Wu, Eric H. Jordan, et al. "The Solution Precursor Plasma Spray Process for Making Durable Thermal Barrier Coatings." In ASME Turbo Expo 2005: Power for Land, Sea, and Air. ASMEDC, 2005. http://dx.doi.org/10.1115/gt2005-68942.

Full text
Abstract:
The Solution Precursor Plasma Spray (SPPS) process involves the injection of atomized droplets of precursor into the plasma plume, instead of powder that is used in conventional plasma spray. The resultant thermal barrier coating (TBC) microstructure consists of (1) through-coating-thickness cracks, (2) ultra-fine splats, and (3) nanometer and micrometer-sized dispersed pores. These unique SPPS microstructural features provide highly durable TBCs. The SPPS TBCs in 1121°C /1 hour cyclic furnace tests exhibit a significantly improved spallation life compared to APS, DVC, and EB-PVD/Pt-Al TBCs. Extensive process diagnostic and modeling studies have been conducted to provide a foundation for understanding and control of the process. Process/microstructure/property relationships have been defined. Extension of the process for making thick coatings (&gt; 3mm) and low thermal conductivity coatings are described.
APA, Harvard, Vancouver, ISO, and other styles
10

Manyasi, Chakrit. "The Challenging S1 Sirikit Large EOR Project in Thailand." In SPE Conference at Oman Petroleum & Energy Show. SPE, 2025. https://doi.org/10.2118/225061-ms.

Full text
Abstract:
Objective/Scope This paper discusses the S1 Sirikit Big Enhance Oil Recovery (EOR) polymer injection project, which has received approval to be expanded across the entire S1 region. In 2019, large-scale EOR activities began and continue until 2024. During this period, six different polymer injection units were installed and operated in the defined region. They were able to demonstrate that they met the specified flow rate and viscosity requirements. The flow rate is designed to accommodate a maximum capacity of 1200 barrels per day (BPD) at a pressure range of 0 to 1800 PSIG. Method,Procedure, and Process To sum up, the S1 region has been implementing polymer EOR since 2019. The EOR package unit includes a polymer preparation skid, maturation tank, polymer transfer pump (PCP), high pressure polymer injection pump (HP), static mixer, and dilution water booster pump. Off-skid facilities, including a filter, strainer toilet, and utility tank skid were also developed and established as well as an EOR polymer injection line. Each EOR device is capable of modifying the final solution polymer injection rates to match the requirements of diverse locales. For instance, some sites have a subsurface requirement of lower viscosity, such as 23cP, whereas others have different requirements. In case that the viscosity is higher like 40 cP, the project will design and deliver thorough coverage of the injection condition on site as the condition will be relocated once the injection is finished. The unit is authorized to be constructed and be able to remove upon the completion of three years of production period. All of the equipment is stored in the standard container, and the lifting lug is also included in the equipment at the skid. The Ping well supplies the water, which undergoes purification before it enters the unit. The water leaves by two separate routes: 1) To obtain the mother solution which requires the flowrate of approximately 3500 BPD; this stream is going to mixing equipment and go to maturation tank; 2) To adequately dilute with polymer before injecting into the well, the required flowrate is 1,500 - 9,500 BPD; this stream will then mix with the mother solution from the HP pump at the upstream of the static mixer and then mix according to the specified ratio between the mother solution and water. A mixture of water and polymer powder is stirred in a maturation tank to generate the mother solution. The ratio of water to polymer powder was determined and blended in a polymer preparation skid that featured a storage silo, a conveyor, and mixing machinery. The concentration of the mixture ranged from 3,000 to 10,000 ppm. After that, a PCP pump transfers the fluid to a high-pressure injection pump (HP pump), which operates at a variable speed. The PCP pump can transport a maximum of 1834 BPD (3x50%), but the HP injection system can manage a flowrate of approximately 33.33 to 330.3 BPD with variable speed drive (VSD). The operator can utilize the HMI panel to alter the ratio of final solutions to polymer preparation. The final solution injections range between 2,000 and 10,000 BPD. Before going to the well, the mixture is mixed in a static mixer that can handle between 200 and 1,200 BPD. See Tables 1 and 2 for more details.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!